These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 11906495)
41. [Atherosclerosis as an infectious disease]. Visseren FL; Erkelens DW Ned Tijdschr Geneeskd; 1999 Feb; 143(6):291-5. PubMed ID: 10221083 [TBL] [Abstract][Full Text] [Related]
42. Is there an infective aetiology to atherosclerosis? Gupta S; Camm AJ Drugs Aging; 1998 Jul; 13(1):1-7. PubMed ID: 9679204 [TBL] [Abstract][Full Text] [Related]
43. Antibiotics effects in a rabbit model of Chlamydia pneumoniae-induced atherosclerosis. Fong IW J Infect Dis; 2000 Jun; 181 Suppl 3():S514-8. PubMed ID: 10839750 [TBL] [Abstract][Full Text] [Related]
44. Chlamydia pneumoniae and atherosclerosis: from Koch postulates to clinical trials. Liu C; Waters DD Prog Cardiovasc Dis; 2005; 47(4):230-9. PubMed ID: 15991152 [TBL] [Abstract][Full Text] [Related]
45. Animal models of chlamydia and atherosclerosis. Muhlestein JB Am Heart J; 1999 Nov; 138(5 Pt 2):S514-5. PubMed ID: 10539862 [No Abstract] [Full Text] [Related]
46. [Chlamydia pneumoniae and atherosclerosis]. Marre R; Essig A Dtsch Med Wochenschr; 1997 Sep; 122(36):1092-5. PubMed ID: 9333534 [No Abstract] [Full Text] [Related]
48. Chlamydia pneumoniae and anti-infective therapy: their role in the pathogenesis and treatment of coronary artery disease. Behbahani R; Verme-Gibboney C; Romanelli AM Clin Ther; 1999 Aug; 21(8):1286-300; discussion 1285. PubMed ID: 10485501 [TBL] [Abstract][Full Text] [Related]
49. Chlamydia pneumoniae and atherosclerosis. Wong YK; Gallagher PJ; Ward ME Heart; 1999 Mar; 81(3):232-8. PubMed ID: 10026342 [TBL] [Abstract][Full Text] [Related]
50. Chronic infection in the etiology of atherosclerosis--the case for Chlamydia pneumoniae. Gupta S; Camm AJ Clin Cardiol; 1997 Oct; 20(10):829-36. PubMed ID: 9377818 [TBL] [Abstract][Full Text] [Related]
51. Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model. Muhlestein JB; Anderson JL; Hammond EH; Zhao L; Trehan S; Schwobe EP; Carlquist JF Circulation; 1998 Feb; 97(7):633-6. PubMed ID: 9495296 [TBL] [Abstract][Full Text] [Related]
52. Epidemiology of Chlamydia pneumoniae in atherosclerosis. Saikku P Am Heart J; 1999 Nov; 138(5 Pt 2):S500-3. PubMed ID: 10539858 [TBL] [Abstract][Full Text] [Related]
53. [Atherosclerosis and inflammation--role of chlamydia pneumoniae infection what do we know to date?]. Fudal M; Wilczewski P Wiad Lek; 2004; 57(3-4):151-5. PubMed ID: 15307523 [TBL] [Abstract][Full Text] [Related]
54. Emerging concepts in disease management: a role for antimicrobial therapy in coronary artery disease. Girard SE; Temesgen Z Expert Opin Pharmacother; 2001 May; 2(5):765-72. PubMed ID: 11336621 [TBL] [Abstract][Full Text] [Related]
55. [The infection theory in atherosclerosis]. Capron L; Wyplosz B Arch Mal Coeur Vaiss; 1998 Oct; 91 Spec No 5():21-6. PubMed ID: 9833076 [TBL] [Abstract][Full Text] [Related]
56. Dissemination of Chlamydia pneumoniae to the vessel wall in atherosclerosis. Hirono S; Pierce GN Mol Cell Biochem; 2003 Apr; 246(1-2):91-5. PubMed ID: 12841348 [TBL] [Abstract][Full Text] [Related]